GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Monash IVF Group Ltd (ASX:MVF) » Definitions » Total Stockholders Equity

Monash IVF Group (ASX:MVF) Total Stockholders Equity : A$276.4 Mil (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Monash IVF Group Total Stockholders Equity?

Monash IVF Group's Total Stockholders Equity for the quarter that ended in Dec. 2023 was A$276.4 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Monash IVF Group's Book Value per Share for the quarter that ended in Dec. 2023 was A$0.71. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Monash IVF Group's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.44.

Monash IVF Group Total Stockholders Equity Historical Data

The historical data trend for Monash IVF Group's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Monash IVF Group Total Stockholders Equity Chart

Monash IVF Group Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 173.22 249.81 266.68 267.92 273.20

Monash IVF Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 270.31 267.92 270.14 273.20 276.44

Monash IVF Group  (ASX:MVF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Monash IVF Group's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(276.437-0)/389.635
=0.71

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Monash IVF Group's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(49.737 + 72.005) / 276.437
=0.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Monash IVF Group Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Monash IVF Group's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Monash IVF Group (ASX:MVF) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Monash IVF Group Ltd (ASX:MVF) » Definitions » Total Stockholders Equity
Comparable Companies
ASX:ACL ASX:IDX ASX:MAP ASX:GSS ASX:IIQ ASX:RHY ASX:LDX ASX:CTE ASX:BDX ASX:GTG TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN
Traded in Other Exchanges
MIS:Germany
Address
510 Church Street, Level 1, Cremorne, Cremorne, VIC, AUS, 3121
Website
https://www.monashivfgroup.com.au
Monash IVF Group Ltd is a specialist assisted reproductive services provider. The company offers specialist diagnostic obstetric and gynaecological ultrasound and fertility treatments. The company's operating segment includes Australia and International. It generates maximum revenue from the Australian segment. Australian segment is a provider of Assisted Reproductive Services, Ultrasound, and other related services. The International segment is a provider of Assisted Reproductive Services in Malaysia.